NYSE · CHEMICALS & ALLIED PRODUCTS · LARGE CAP
Huntsman Corporation HUN
18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$5.7B
▼ 5.8% vs FY2024
EPS · FY25
$-1.65
Dividend / sh · FY25
$0.84
Payout · FY25
-51%
ROE · FY25
-9.9%
Net margin · FY25
-5.0%
Dividend coverage
-2.0×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 5.7B
Revenue, FY2025 · full 18-year series below
Revenue
Net income
The company lost 5 cents on every revenue dollar this year.
Per share
USD -1.65
Diluted EPS, FY2025
EPS
Dividend
The dividend was paid in a year without profit.
Profitability
-9.9%
Return on equity, FY2025
ROE
Operating margin-2.3%
Net margin-5.0%
Return on assets-4.0%
Each USD of equity lost 10 cents this year.
Returned to shareholders
USD 146.0M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 146.0M
Net buybacksUSD 0.00
Share of profit-51.4%
Consecutive raises—
USD 146.0M in dividends went back to shareholders in a year without profit.
Growth
+0.9% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−10.9%
+0.9%
−3.5%
−3.2%
Dividend / share
−0.5%
+5.2%
+5.3%
+5.0%
Returned to shareholders
−50.0%
−9.2%
−4.0%
+2.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.17B
Shares outstanding, FY2025
Change, 5 years−21.6%
Change, 10 years−27.2%
The share count shrank 22% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 7.0B
total assets, end of FY2025
Total assetsUSD 7.0B
EquityUSD 2.8B
CashUSD 429.0M
Gross debtUSD 2.0B
Net debtUSD 1.6B
Current ratio1.30×
Net debt stands at 58% of equity.
History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
5.7
6.0
6.1
8.0
7.7
5.4
6.8
7.6
6.8
7.5
8.1
11.6
11.1
11.2
11.2
9.2
7.7
10.1
Operating income $B
−0.1
−0.0
0.1
0.7
0.7
0.4
0.5
0.8
0.7
0.7
0.7
0.6
0.5
0.8
0.6
0.4
0.0
0.2
EBITDA $B
0.2
0.3
0.4
1.0
1.0
0.7
0.7
1.1
1.0
1.0
1.0
1.1
1.0
1.3
1.0
0.8
0.5
0.6
Income tax $B
0.0
0.1
0.1
0.2
0.2
0.0
−0.0
0.0
0.0
0.1
0.1
0.1
0.1
0.2
0.1
0.0
0.4
0.2
Net income $B
−0.3
−0.2
0.1
0.5
1.0
1.0
0.6
0.3
0.6
0.3
0.1
0.3
0.1
0.4
0.2
0.0
0.1
0.6
EPS, diluted $
−1.65
−1.10
0.57
2.27
4.72
4.66
2.44
1.39
2.61
1.36
0.38
1.31
0.53
1.51
1.02
0.11
0.48
2.60
Dividend / sh $
0.84
1.00
0.95
0.85
0.75
0.65
0.65
0.65
0.50
0.50
0.50
0.50
0.50
0.40
0.40
0.40
0.40
0.40
Payout %
−51
−92
167
37
15
14
27
46
19
37
130
37
94
26
39
356
84
15
ROE %
−9.9
−6.1
2.9
11.5
26.5
33.3
21.6
13.1
32.6
23.9
5.8
17.2
6.8
21.1
14.3
1.5
6.6
37.8
Shares out B
0.17
0.17
0.17
0.18
0.21
0.22
0.22
0.23
0.24
0.24
0.24
0.24
0.24
0.24
0.24
0.24
0.23
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
70 of 70
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed